AnaptysBio (NASDAQ:ANAB) reported its Q4 earnings results on Monday, March 7, 2022 at 09:00 AM.
Here's what investors need to know about the announcement.
Earnings
AnaptysBio reported an EPS of $-1.18.
Revenue was down $58.99 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.67 which was followed by a 7.45% increase in the share price the next day.
Here's a look at AnaptysBio's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.91 | -0.11 | -0.69 | 1.39 |
| EPS Actual | -0.24 | -0.02 | -0.66 | 1.20 |
| Revenue Estimate | 6.67M | 28.88M | 9.39M | 64.00M |
| Revenue Actual | 20.89M | 30.03M | 11.25M | 60.00M |
Listen to the earnings announcement yourself by clicking here.
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
